TY - JOUR
T1 - The impact of coronary artery disease on outcomes after liver transplantation
AU - Skaro, Anton I.
AU - Gallon, Lorenzo G.
AU - Lyuksemburg, Vadim
AU - Jay, Colleen L.
AU - Zhao, Lihui
AU - Ladner, Daniela P.
AU - VanWagner, Lisa B.
AU - De Wolf, Andre M.
AU - Flaherty, James D.
AU - Levitsky, Josh
AU - Abecassis, Michael M.
AU - Gheorghiade, Mihai
N1 - Publisher Copyright:
© 2016 Italian Federation of Cardiology. All rights reserved.
PY - 2016/11/13
Y1 - 2016/11/13
N2 - Aims: The aim of this study is to assess the impact of obstructive coronary artery disease (CAD) on outcomes after liver transplantation. Background Patients considered for liver transplantation are at an increased risk for CAD. Obstructive CAD is a contraindication for liver transplantation at most centres. However, the association between severity of CAD and liver transplantation outcomes remains poorly characterized. Methods: We retrospectively reviewed 386 consecutive liver transplantations performed between January 2001 and December 2005 at NorthwesternMemorial Hospital (NMH). A comparative analysis was conducted for a national cohort (n=23 820) from the United Network for Organ Sharing database. Outcome measures included patient and graft survival, rates of acutemyocardial infarction and heart failure. Results: Patient survival remained similar irrespective of CAD severity or cardiovascular risk index (CRI) in the NMH cohort. The CRI closely correlated with the presence of CAD in the NMH cohort [CRI 0, odds ratio (OR) 0.125, 95% confidence interval (95% CI) 0.02-0.61, P=0.01; CRI 1, OR 1 reference; CRI ≥-2, OR 2.28, 95% CI 1.09-4.75, P=0.02]. In the national cohort using Cox regression, high (≥- 2) CRI (reference 0, hazard ratio 1.376, 95% CI 1.271-1.488, P<0.0001) predicted patient mortality and exceeded established risk factors, including Hepatitis C virus (HCV) (hazard ratio 1.321, 95% CI 1.242-1.403, P<0.0001), hepatocellular carcinoma (HCC) (hazard ratio 1.27, 95% CI 1.181-1.370, P<0.0001) and diabetes (hazard ratio 1.241, 95% CI 1.160-1.326, P<0.0001). Conclusion: Liver transplantation in patients with CAD is not associated with prohibitive risk for cardiac events and patient mortality. Appropriately treated CAD should therefore not represent a contraindication to liver transplantation.
AB - Aims: The aim of this study is to assess the impact of obstructive coronary artery disease (CAD) on outcomes after liver transplantation. Background Patients considered for liver transplantation are at an increased risk for CAD. Obstructive CAD is a contraindication for liver transplantation at most centres. However, the association between severity of CAD and liver transplantation outcomes remains poorly characterized. Methods: We retrospectively reviewed 386 consecutive liver transplantations performed between January 2001 and December 2005 at NorthwesternMemorial Hospital (NMH). A comparative analysis was conducted for a national cohort (n=23 820) from the United Network for Organ Sharing database. Outcome measures included patient and graft survival, rates of acutemyocardial infarction and heart failure. Results: Patient survival remained similar irrespective of CAD severity or cardiovascular risk index (CRI) in the NMH cohort. The CRI closely correlated with the presence of CAD in the NMH cohort [CRI 0, odds ratio (OR) 0.125, 95% confidence interval (95% CI) 0.02-0.61, P=0.01; CRI 1, OR 1 reference; CRI ≥-2, OR 2.28, 95% CI 1.09-4.75, P=0.02]. In the national cohort using Cox regression, high (≥- 2) CRI (reference 0, hazard ratio 1.376, 95% CI 1.271-1.488, P<0.0001) predicted patient mortality and exceeded established risk factors, including Hepatitis C virus (HCV) (hazard ratio 1.321, 95% CI 1.242-1.403, P<0.0001), hepatocellular carcinoma (HCC) (hazard ratio 1.27, 95% CI 1.181-1.370, P<0.0001) and diabetes (hazard ratio 1.241, 95% CI 1.160-1.326, P<0.0001). Conclusion: Liver transplantation in patients with CAD is not associated with prohibitive risk for cardiac events and patient mortality. Appropriately treated CAD should therefore not represent a contraindication to liver transplantation.
KW - Coronary disease
KW - Liver
KW - Transplantation
UR - http://www.scopus.com/inward/record.url?scp=84919665657&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84919665657&partnerID=8YFLogxK
U2 - 10.2459/JCM.0000000000000207
DO - 10.2459/JCM.0000000000000207
M3 - Article
C2 - 25517876
AN - SCOPUS:84919665657
SN - 1558-2027
VL - 17
SP - 875
EP - 885
JO - Journal of Cardiovascular Medicine
JF - Journal of Cardiovascular Medicine
IS - 12
ER -